An anti-CD52 ANTIGEN monoclonal antibody used for the treatment of certain types of CD52-positive lymphomas (e.g., CHRONIC LYMPHOCYTIC LEUKEMIA; CUTANEOUS T-CELL LYMPHOMA; and T-CELL LYMPHOMA). Its mode of actions include ANTIBODY-DEPENDENT CELL CYTOTOXICITY.
Synonyms: Campath 1 G, Campath-1-G, Campath1G, Campath1H, Campath-1H, Lemtrada, Monoclonal Antibody Campath 1H, Alemtuzumab, Campath-1M, 3A189DH42V, Campath-1H, Monoclonal Antibody, Campath, 0, Campath 1M, Antibody Campath-1H, Monoclonal, Campath-1G, MabCambath, Campath 1H, Campath 1G, Monoclonal Antibody Campath-1H
Instance information
2018; ALEMTUZUMAB was indexed under ANTIBODIES, MONOCLONAL, 1995-2011 and under ANTIBODIES, MONOCLONAL, HUMANIZED, 2012-2017 ,2018 (1995)
D000074323